ARTICLE | Company News
Diamyd, J&J deal
June 6, 2011 7:00 AM UTC
Johnson & Johnson's Ortho-McNeil-Janssen Pharmaceuticals Inc. subsidiary terminated a 2010 deal with Diamyd and returned rights to diabetes candidate Diamyd. In May, the product missed the primary end...